[ad_1]
Amedica (NASDAQ:AMDA) and Mazor Robotics (NASDAQ:MZOR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.
Profitability
This table compares Amedica and Mazor Robotics’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Amedica | -139.62% | -148.60% | -67.83% |
Mazor Robotics | -37.29% | -7.70% | -6.64% |
Risk and Volatility
Amedica has a beta of -1.24, indicating that its stock price is 224% less volatile than the S&P 500. Comparatively, Mazor Robotics has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.
Institutional and Insider Ownership
3.7% of Amedica shares are owned by institutional investors. Comparatively, 32.7% of Mazor Robotics shares are owned by institutional investors. 0.9% of Amedica shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Amedica and Mazor Robotics’ revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Amedica | $11.23 million | 0.00 | -$9.32 million | ($3.13) | N/A |
Mazor Robotics | $64.95 million | 0.00 | -$12.41 million | ($0.50) | N/A |
Amedica has higher earnings, but lower revenue than Mazor Robotics.
Analyst Recommendations
This is a breakdown of recent recommendations for Amedica and Mazor Robotics, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Amedica | 0 | 1 | 0 | 0 | 2.00 |
Mazor Robotics | 0 | 3 | 0 | 0 | 2.00 |
Mazor Robotics has a consensus target price of $59.50, indicating a potential upside of ∞.
Summary
Mazor Robotics beats Amedica on 7 of the 10 factors compared between the two stocks.
Amedica Company Profile
Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers silicon nitride implants to surgeons and hospitals for use in cervical and thoracolumbar spine surgery under the Valeo brand. It also provides a line of non-silicon nitride spinal fixation products to address spinal deformity and degenerative conditions. The company markets and sells its products directly; and through a network of independent sales distributors, as well original equipment manufacturer and private label partnerships. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah.
Mazor Robotics Company Profile
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company’s surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.
Receive News & Ratings for Amedica Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Amedica and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link
Leave A Comment
You must be logged in to post a comment.